Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lenche Chakievska

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 25, 2020
Adjuvant treatment with secukinumab induced long term remission in a patient with severe bullous pemphigoidMaike Marleen Holtsche, Christoph Matthias Hammers, Lenche Chakievska, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 29, 2020
Maike Marleen Holtsche, Christoph Matthias Hammers, Lenche Chakievska, et al.
Diabetes Care|December 16, 2025
Stratifying the Rate of Disease Progression by Progression Likelihood Scores in Children and Adolescents With Stage 1 and Stage 2 Type 1 Diabetes in GermanyAndreas Weiss, Lenche Chakievska, Peter Achenbach, et al.
Frontiers in Immunology|February 24, 2022
Increased Fibrosis in a Mouse Model of Anti-Laminin 332 Mucous Membrane Pemphigoid Remains Unaltered by Inhibition of Aldehyde DehydrogenaseSabrina Patzelt, Manuela Pigors, Heiko Steenbock, et al.
Journal of Autoimmunity|September 17, 2018
IL-17A is functionally relevant and a potential therapeutic target in bullous pemphigoidLenche Chakievska, Maike M Holtsche, Axel Künstner, et al.
The Journal of Investigative Dermatology|January 22, 2017
The Leukotriene B<sub>4</sub> and its Receptor BLT1 Act as Critical Drivers of Neutrophil Recruitment in Murine Bullous Pemphigoid-Like Epidermolysis Bullosa AcquisitaTanya Sezin, Matthias Krajewski, Adam Wutkowski, et al.
Journal of Autoimmunity|August 20, 2024
High throughput screening identifies repurposable drugs for modulation of innate and acquired immune responsesSaeedeh Ghorbanalipoor, Kazuko Matsumoto, Natalie Gross, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 25, 2020
Adjuvant treatment with secukinumab induced long term remission in a patient with severe bullous pemphigoidMaike Marleen Holtsche, Christoph Matthias Hammers, Lenche Chakievska, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 29, 2020
Maike Marleen Holtsche, Christoph Matthias Hammers, Lenche Chakievska, et al.
Diabetes Care|December 16, 2025
Stratifying the Rate of Disease Progression by Progression Likelihood Scores in Children and Adolescents With Stage 1 and Stage 2 Type 1 Diabetes in GermanyAndreas Weiss, Lenche Chakievska, Peter Achenbach, et al.
Frontiers in Immunology|February 24, 2022
Increased Fibrosis in a Mouse Model of Anti-Laminin 332 Mucous Membrane Pemphigoid Remains Unaltered by Inhibition of Aldehyde DehydrogenaseSabrina Patzelt, Manuela Pigors, Heiko Steenbock, et al.
Journal of Autoimmunity|September 17, 2018
IL-17A is functionally relevant and a potential therapeutic target in bullous pemphigoidLenche Chakievska, Maike M Holtsche, Axel Künstner, et al.
The Journal of Investigative Dermatology|January 22, 2017
The Leukotriene B<sub>4</sub> and its Receptor BLT1 Act as Critical Drivers of Neutrophil Recruitment in Murine Bullous Pemphigoid-Like Epidermolysis Bullosa AcquisitaTanya Sezin, Matthias Krajewski, Adam Wutkowski, et al.
Journal of Autoimmunity|August 20, 2024
High throughput screening identifies repurposable drugs for modulation of innate and acquired immune responsesSaeedeh Ghorbanalipoor, Kazuko Matsumoto, Natalie Gross, et al.
Pageof 1